The PhD in Personalized Medicine and Innovative Therapies promotes cutting-edge research in the field of clinical and translational biomedical sciences, with a strong emphasis on interdisciplinarity and innovation. Research activities encompass a broad spectrum of thematic areas, all oriented towards the advancement of personalized medicine and the development of innovative therapies. 

Doctoral students are involved in research projects ranging from the study of molecular mechanisms of diseases to the application of advanced technologies for personalized diagnosis and therapies. The interdisciplinary approach integrates diverse skills, from genetics to bioinformatics, from immunology to clinical medicine, allowing a holistic view of contemporary biomedical challenges. 

A distinctive aspect of the program is the emphasis on translational research, aiming to bridge the gap between laboratory discoveries and clinical applications. Research projects are often conducted in collaboration with clinical facilities, facilitating the rapid transfer of knowledge from the laboratory bench to the patient's bedside. 

Doctoral students have access to state-of-the-art laboratories, latest-generation sequencing technologies, and advanced data analysis platforms, including artificial intelligence tools. This technologically advanced environment supports the conduct of innovative and internationally competitive research. The program actively promotes collaborations with national and international research groups, offering doctoral students the opportunity to participate in wide-ranging projects of global relevance. Integration into international research networks is further strengthened through participation in conferences and publication of results in high-impact scientific journals. 

This emphasis on frontier research, combined with an interdisciplinary and collaborative approach, prepares doctoral students to face the complex challenges of modern medicine and to contribute significantly to scientific progress in the biomedical field.